Wednesday 22 February 2012

Jubilant Biosys inks drug discovery pact with Mnemosyne Pharma

Jubilant Biosys has entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc to develop molecules for treating mental disorders resulting from diseases of the nervous system.

The alliance shall initially span a period of two years and may be extended on mutual consent across other therapeutic programs as well.

No comments:

Post a Comment